Galera Therapeutics Inc.
0.05
0.00 (8.46%)
At close: Jan 15, 2025, 8:00 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -59.08M -62.22M -80.53M -74.22M -51.93M -23.68M -23.55M
Depreciation & Amortization 259.00K 114.00K 778.00K 368.00K 267.00K 127.00K 84.00K
Stock-Based Compensation 5.56M 7.16M 7.23M 5.54M 2.39M 865.00K 726.00K
Other Working Capital -721.00K 1.48M -2.53M 2.71M -732.00K -1.29M -19.00K
Other Non-Cash Items 11.34M 11.57M 7.19M 4.88M 3.04M 220.00K 1.61M
Deferred Income Tax n/a -70.00K n/a -16.00K 232.00K n/a n/a
Change in Working Capital -2.93M 17.00K -2.63M 3.91M -655.00K 298.00K -671.00K
Operating Cash Flow -44.85M -43.43M -67.96M -59.54M -46.66M -22.17M -23.41M
Capital Expenditures -59.00K -25.00K -283.00K -457.00K -633.00K -347.00K -319.00K
Acquisitions n/a -24.02K -5.52K -37.00K 27.19K n/a n/a
Purchase of Investments -22.64M -59.89M -71.98M -67.75M -123.19M -71.19M -9.92M
Sales Maturities Of Investments 49.99M 83.91M 77.50M 104.75M 96.00M 12.50M 33.75M
Other Investing Acitivies n/a 24.02K 5.52K 37.00K -27.19K -58.69M 23.83M
Investing Cash Flow 27.29M 23.99M 5.24M 36.55M -27.82M -59.04M 23.51M
Debt Repayment n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 2.20M 81.00K 58.77M 20.51M 20.01M 89.84M n/a
Financial Cash Flow 31.50M 3.89M 66.71M 20.51M 78.03M 89.84M n/a
Net Cash Flow 13.94M -15.54M 3.99M -2.48M 3.54M 8.64M 106.00K
Free Cash Flow -44.91M -43.45M -68.24M -59.99M -47.29M -22.51M -23.73M

Create Price Alert on GRTX

Your price alert will notify you when the stock price is above 0.05.

Add to Watchlist